Literature DB >> 26730583

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas).

U-F Pape1, B Niederle, F Costa, D Gross, F Kelestimur, R Kianmanesh, U Knigge, K Öberg, M Pavel, A Perren, C Toumpanakis, J O'Connor, E Krenning, N Reed, D O'Toole.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26730583     DOI： 10.1159/000443165

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  42 in total

1.  Management of pediatric appendiceal carcinoid: a single institution experience from 5000 appendectomies.

Authors:  Chirath Ranaweera; Amanpreet Brar; Gino R Somers; Furqan Sheikh; Agostino Pierro; Augusto Zani
Journal:  Pediatr Surg Int       Date:  2019-09-25       Impact factor: 1.827

Review 2.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

3.  Management and outcome of an appendiceal collision tumour composed of neuroendocrine and mucinous neoplasms.

Authors:  Adam N Sholi; Katherine D Gray; Alfons Pomp
Journal:  BMJ Case Rep       Date:  2019-07-10

Review 4.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

5.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 6.  The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines.

Authors:  Wouter T Zandee; Wouter W de Herder
Journal:  Neuroendocrinology       Date:  2018-01-10       Impact factor: 4.914

7.  Appendiceal goblet cell carcinomas have poor survival despite completion surgery.

Authors:  Edward Alabraba; David Mark Pritchard; Rebecca Griffin; Rafael Diaz-Nieto; Melissa Banks; Daniel James Cuthbertson; Stephen Fenwick
Journal:  Endocrine       Date:  2021-04-23       Impact factor: 3.633

8.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

Review 9.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

Review 10.  Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Andrew M Bellizzi
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.